StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) stock

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.04−0.09 (-7.96%)

Close on Nov 18, 2026Market cap $5.02MP/E –Yield –

Alzamend Neuro market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Alzamend Neuro's market cap was $6.32M on Nov 11, 2026, against $6.88M a year earlier. Over the last 5 years it ranged from $366.55K to $589.31M, with a median of $6.92M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.32M-8.6%
2025Dec 31, 2025$6.92M+592.5%
2024Dec 31, 2024$999.16K-82.6%
2023Dec 29, 2023$5.76M-89.3%
2022Dec 30, 2022$53.94M-71.0%
2021Nov 30, 2021$185.93M–

More Alzamend Neuro figures

See a number that looks wrong?